COMMUNIQUÉS West-GlobeNewswire
-
RÉALISATION DE L'ÉMISSION PAR GENFIT D'OBLIGATIONS À OPTION DE CONVERSION ET/OU D'ÉCHANGE EN ACTIONS NOUVELLES ET/OU EXISTANTES (« OCEANE ») A ÉCHÉANCE 2022 POUR UN MONTANT DE 180 MILLIONS D'EUROS
17/10/2017 - 08:30 -
GENFIT COMPLETES A €180 MILLION OFFERING OF BONDS CONVERTIBLE INTO NEW SHARES AND/OR EXCHANGEABLE FOR EXISTING SHARES ("OCEANEs") DUE 2022
17/10/2017 - 08:30 -
Helsinn Pharmaceuticals (Beijing) Co. Ltd. Opens Office in Shanghai, China
17/10/2017 - 08:30 -
World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions
17/10/2017 - 08:16 -
Conférence de presse du dimanche de la Conférence mondiale sur le cancer du poumon : présentation de nouveaux prix et lignes directrices mondiales
17/10/2017 - 03:45 -
Ossur Hf : Transactions in relation to share buyback program
16/10/2017 - 18:00 -
Invitation to Idorsia's nine-month results 2017 webcast and conference call
16/10/2017 - 17:35 -
LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in Berlin
16/10/2017 - 15:00 -
Medtronic Care Management Services and American Well Announce Strategic Partnership to Integrate Telehealth Capabilities
16/10/2017 - 15:00 -
Novo Nordisk: FDA posts briefing materials prior to Advisory Committee meeting for semaglutide
16/10/2017 - 14:08 -
Genedrive PLC: genedrive signs distribution agreement with Sysmex Europe GmbH("Sysmex Europe")
16/10/2017 - 14:00 -
Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis
16/10/2017 - 14:00 -
Sanofi et Regeneron annoncent les résultats positifs d'une étude de phase 2 du dupilumab dans le traitement de l'oesophagite à éosinophiles modérée à sévère de l'adulte
16/10/2017 - 14:00 -
Novo Nordisk A/S - Share repurchase programme
16/10/2017 - 12:39 -
UZA, UZ Gent and AZ Sint-Lucas Gent select Cerner for their new EHR projects
16/10/2017 - 12:00 -
Une avancée majeure dans le marché de la santé en Belgique
16/10/2017 - 12:00 -
Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK(TM) (sodium thiosulfate) Presented at the 49th Congress of the International Society of Pediatric Oncology (SIOP) 2017 Meeting
16/10/2017 - 12:00 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
16/10/2017 - 09:00 -
Solon Eiendom ASA : Primary insider notification
16/10/2017 - 08:30
Pages